Infectious Disease
Home Infectious Disease
Recombinant Zoster Vaccine Cost-Effective in Simulation
Incremental cost-effectiveness ratio varied from $10,000 to $47,000 per QALY for RZV versus no vaccine
CDC: Heterosexual Syphilis Transmission Up for Drug Users
Substantial proportion of heterosexual syphilis transmission seen in drug users, especially meth users
Hospital Prices Growing Faster Than Physician Prices
Efforts to reduce health care spending should focus on hospital prices
Sepsis Common in Terminal Hospitalizations, Discharges
Most common underlying causes of death in sepsis are solid and hematologic cancers, chronic heart disease
Risk for MRSA Reduced With Postdischarge Decolonization
Risk for MRSA infections, infections from any cause further reduced with full adherence to decolonization
Child Enterovirus Infection May Up Risk for Developing Celiac Disease
Correlation seen for infections after introduction of gluten; no link for adenovirus
High Rates of MenB Vaccination Advised in University Outbreaks
Estimated first-dose vaccination coverage varied from 14 to 98 percent in 10 university outbreaks
CDC: Severity of Influenza Season Low Through Feb. 2, 2019
Vaccine effectiveness 47 percent against all flu virus infection associated with acute respiratory illness
Sinks by Toilets in ICU Patient Rooms Harbor Harmful Bacteria
Klebsiella pneumonia carbapenemase more common in sinks near toilets
Progress Made in Developing New Antibacterial Agents
But most recently approved agents have been modifications of existing chemical classes of antibiotics
